Liaoning He Eye Hospital Group Co., LTD. (SHE:301103)
China · Delayed Price · Currency is CNY 17.00
-0.04 (-0.23%)
At close: May 29, 2026
SHE:301103 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 27.49 | 27.34 | -27.4 | 63.55 | 32.59 | 86.36 |
Depreciation & Amortization | 98.62 | 98.62 | 111.7 | 110.68 | 105.07 | 98.61 |
Other Amortization | 33.78 | 33.78 | 35.31 | 28.73 | 22.02 | 19.31 |
Loss (Gain) From Sale of Assets | -0.75 | -0.75 | -1.4 | -3.53 | 0.06 | 0.31 |
Asset Writedown & Restructuring Costs | 4.83 | 4.83 | 2.28 | 5.16 | 1.91 | 1.6 |
Loss (Gain) From Sale of Investments | -14.45 | -14.45 | -1.45 | -3.17 | - | - |
Other Operating Activities | 3.81 | 7.84 | 3.45 | 7.84 | 10.57 | 12.1 |
Change in Accounts Receivable | 4.38 | 4.38 | 46.91 | -54.47 | -13.02 | -1.66 |
Change in Inventory | 1.19 | 1.19 | 8.71 | -2.52 | -11.63 | -2.83 |
Change in Accounts Payable | -2.53 | -2.53 | -22.23 | 23.31 | 1.31 | 0.94 |
Change in Other Net Operating Assets | -1.73 | -1.73 | -0.23 | -0.55 | -0.1 | -0.24 |
Operating Cash Flow | 153.07 | 156.93 | 155.65 | 176.77 | 147.98 | 213.61 |
Operating Cash Flow Growth | -13.61% | 0.83% | -11.95% | 19.46% | -30.72% | 25.84% |
Capital Expenditures | -36.91 | -33.75 | -116.33 | -188.51 | -49.11 | -71.22 |
Sale of Property, Plant & Equipment | - | - | - | - | - | 0.24 |
Investment in Securities | -206.2 | -293 | -643.2 | 200 | -200 | - |
Other Investing Activities | 16.41 | 16.31 | 0.53 | 2.54 | - | - |
Investing Cash Flow | -226.7 | -310.44 | -759 | 14.03 | -249.11 | -70.99 |
Long-Term Debt Repaid | - | -50.58 | -60.76 | -63.77 | -64.19 | -54.45 |
Net Debt Issued (Repaid) | -50.58 | -50.58 | -60.76 | -63.77 | -64.19 | -54.45 |
Issuance of Common Stock | - | - | - | - | 1,198 | - |
Repurchase of Common Stock | - | - | -63.38 | -4.22 | - | - |
Common Dividends Paid | -23.3 | -23.3 | -93.97 | -158.03 | -72.94 | - |
Other Financing Activities | -1.51 | 0.24 | - | -15.34 | -20.05 | -3.27 |
Financing Cash Flow | -75.38 | -73.63 | -218.1 | -241.36 | 1,041 | -57.72 |
Foreign Exchange Rate Adjustments | -0.06 | 0 | 0.01 | 0 | - | - |
Net Cash Flow | -149.07 | -227.14 | -821.44 | -50.56 | 939.92 | 84.9 |
Free Cash Flow | 116.16 | 123.19 | 39.31 | -11.74 | 98.87 | 142.38 |
Free Cash Flow Growth | 46.63% | 213.33% | - | - | -30.56% | 85.92% |
Free Cash Flow Margin | 10.50% | 11.27% | 3.59% | -0.99% | 10.35% | 14.79% |
Free Cash Flow Per Share | 0.73 | 0.78 | 0.25 | -0.07 | 0.67 | 1.20 |
Cash Income Tax Paid | - | 0.06 | 0.27 | 88.18 | 74.54 | 88.76 |
Levered Free Cash Flow | 122.04 | 127.58 | 51.42 | -31.3 | 100.52 | 130.65 |
Unlevered Free Cash Flow | 127.19 | 133.06 | 58.51 | -22.79 | 108.13 | 138.21 |
Change in Working Capital | -0.26 | -0.26 | 33.16 | -32.49 | -24.25 | -4.68 |